Brief: MediPharm Labs Begins Production Of First Order For International Expansion Of Novel Cannabis Metered Dose Portfolio In EU And United Kingdom
26/05/2025 13:04
May 26 (Reuters) - Medipharm Labs Corp LABS.TO: MEDIPHARM LABS BEGINS PRODUCTION OF FIRST ORDER FOR INTERNATIONAL EXPANSION OF NOVEL CANNABIS METERED DOSE PORTFOLIO IN THE EU AND UNITED KINGDOM UNDER BLACKPOINT SALES AND DISTRIBUTION AGREEMENT Source text: ID:nGNX3lMdQ7 Further company coverage: LABS.TO ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Medipharm Labs
See all newsCanada's MediPharm Labs Q2 revenue rises 11% on international growth
Brief: MediPharm Labs Q2 Revenue CAD 10 Million
Canada's MediPharm Labs reports positive Q1 adjusted EBITDA
Canada's MediPharm Labs FY revenue rises 8% on international sales
Brief: Medipharm Labs Reports Full Year & Fourth Quarter 2025 Results With Over 40% Annual Growth In International Medical Revenue